Events

CardioPharmaGENET was presented at the 14th ISABS & Mayo Clinic Conference: Advances in Application of Artificial Intelligence in Precision Medicine, held in Dubrovnik, Croatia. The conference brought together leading experts from academia, healthcare, and industry to discuss the latest developments in precision medicine, artificial intelligence, and genomics.During the conference, the Chair of the CardioPharmaGENET, Dr….

Advancing precision cardiovascular medicine requires strong integration between scientific research, clinical innovation, and evidence-based policymaking. Within this context, members of the CardioPharmaGENET (CA24165) community continue to contribute actively not only to scientific development, but also to shaping European health policy frameworks. A productive meeting took place in Brussels between Jonathan Gomez-Raja, Management Committee representative for…

Productive discussions were held in Brussels within the framework of CardioPharmaGENET (CA24165), reflecting the Action’s continued commitment to strengthening interdisciplinary collaboration at the interface of cardiovascular challenges and translational precision medicine. The activities in Brussels, attended by SCC dr. Theodora Katsila, combined scientific exchange and capacity-building perspectives, highlighting the importance of effective communication and coordinated…

Members of the CardioPharmaGENET COST Action gathered from 11–13 May 2026 in Darmstadt for the Annual Meeting hosted at GSI Helmholtzzentrum für Schwerionenforschung. The three-day meeting brought together researchers, clinicians, industry representatives, patient stakeholders, policymakers, and Young Research Investigators from across Europe to discuss recent developments, strengthen collaborations, and define future directions in cardiovascular pharmacogenomics and precision medicine. The Annual…

Yvan Devaux, Co-Chair of the CardioPharmaGENET Action, delivered a lecture on precision medicine within the brain–heart axis at the FOKUS Patient Future Days in Stockholm. His presentation highlighted the importance of integrating molecular, clinical, and computational approaches to better understand the complex interactions between neurological and cardiovascular systems.This contribution reflects the ongoing commitment of CardioPharmaGENET…